PBL's Veriplex Human Interferon Multiplex ELISA kit allows life scientists to simultaneously quantify Human Type I, II, and III interferons, as well as pro-inflammatory cytokines, from one sample.
The new multiplex ELISA kit, powered by Quanysys Biosciences' Q-Plex Multiplex ELISA technology, is also compatible with serum/plasma samples.
This simple and cost-effective multiplex ELISA platform can maximise the amount of information obtained from limited sample sources; has a large dynamic range; and is compatible with autoimmune disease matrices.
The company hopes it will have an important role in increasing our understanding of interferon-related immunological events, demonstrating that interferons play integral and diverse roles in many immunological processes.
